IPP Bureau
Medanta launches monthly talk show around cardiac care - 'Heart 2 Heart'
By IPP Bureau - February 15, 2024
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
Mankind Pharma tie-ups with Lepra Society to establish CDCC Centres to screen 80,000 individuals
By IPP Bureau - February 15, 2024
The CDCCs are strategically positioned in regions identified as high-impact areas
UBE announces Phase I clinical trial for SSAO/VAP-1 licensed exclusively to Novo Nordisk
By IPP Bureau - February 15, 2024
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
Ashland launches iSolve information on demand for F&B customers
By IPP Bureau - February 15, 2024
iSolveSM information on demand is the result of our focus on customer relationship
Aparna Group forays into pharma business; Receives USFDA clearance for manufacturing unit
By IPP Bureau - February 15, 2024
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Ascentage Pharma’s Phase III study of Olverembatinib cleared by FDA
By IPP Bureau - February 14, 2024
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
Roche collaborates with PathAI to expand digital pathology capabilities for companion diagnostics
By IPP Bureau - February 14, 2024
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Roche launches three new Factor Xa inhibitor coagulation tests
By IPP Bureau - February 14, 2024
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
Lupin launches Bromfenac Ophthalmic Solution, 0.075% in US
By IPP Bureau - February 14, 2024
Bromfenac Ophthalmic Solution 0.075% (RLD BromSite) had estimated annual sales of USD 15 million in the U.S.
Dr Mandaviya delivers keynote address at 5th Foundation Day of National Cancer Institute, AIIMS Jhajjar
By IPP Bureau - February 13, 2024
Launches collaborative centre for translational research in head and neck cancer
GSK Q3 FY 2023-24 revenue at Rs. 805 Cr
By IPP Bureau - February 13, 2024
The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
Sun Pharma included in S&P Global Sustainability Yearbook 2024
By IPP Bureau - February 13, 2024
This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses
Lord's Mark Industries files patent for bio-chemistry reagents; Targets revenue of Rs. 200 Cr
By IPP Bureau - February 13, 2024
These re-agent and diagnostic test kits come with 99.7% accuracy
Zydus receives Tentative Approval from the USFDA for Dexamethasone Tablets USP, 1 mg
By IPP Bureau - February 10, 2024
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
Biocon Biologics partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab
By IPP Bureau - February 10, 2024
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
